Infectious Disease CDMOs

TAPI (Teva API)

Netherlands

TAPI (Teva Active Pharmaceutical Ingredients) is the API division of Teva Pharmaceutical Industries, positioned as the world's leading international supplier of APIs with 350+ products in their portfolio. They offer integrated API and CDMO services, leveraging 85+ years of API development and manufacturing expertise. TAPI provides customized solutions including complex API development, peptide manufacturing (including GLP-1 capability), and end-to-end manufacturing. They have a partnership with Antheia for biosynthetic pharmaceutical ingredients and with Sagimet Biosciences for resmetirom API. TAPI operates globally with multiple manufacturing sites.

Theon Pharmaceuticals Ltd.

India

Indian pharmaceutical contract manufacturer (third-party manufacturer) based in Baddi, Himachal Pradesh. WHO-GMP and ISO 9001:2008 certified. Specializes in manufacturing tablets, capsules, dry syrups, and injectables. Ranked among top 10 leading injectable companies. Launched new state-of-the-art injectable and ophthalmic formulations facility in October 2024 for regulated markets. Has multiple production sections: General, Beta Lactam, Cephalosporins, Dry Powder Injectable. Exports to Africa, South East Asia, CIS, Latin America, and Asia Pacific. Has 12 FDA-approved products including injectables and oral tablets.

Thermo Fisher Scientific Inc.

China

One of the world's largest pharmaceutical CDMOs through its Patheon pharma services division. Provides end-to-end pharmaceutical development and manufacturing services for both small molecules and biologics, from API manufacturing through drug product, sterile fill/finish, packaging, and commercial supply. Operates 31+ FDA-registered facilities globally. 158 FDA inspections on record (52 NAI, 104 VAI, 2 OAI). Also provides cell therapy manufacturing solutions (CTS Rotea cell processing system), laboratory informatics, bioprocessing equipment, and reagents. 4 FDA-approved drug products. Revenue >$40B (full company).

Tiefenbacher Group

Cyprus

Purpose-driven, family-owned healthcare company pioneering healthcare since 1963, headquartered in Cyprus. Delivers best-in-class solutions across the entire pharmaceutical value chain from API distribution through development, manufacturing, and registration of affordable medicines. 900+ employees, 400+ customers, 180+ finished dosage form products, serving patients in 80+ countries. Production capacity up to 3 billion units per year. Manufacturing sites in Cyprus (large-scale oral solid dose, SPC waiver site) and Hyderabad, India (specialized high-potent manufacturing block for oncology, FDA-inspected). Includes Tiefenbacher Laboratories (TBD Pharmatech) as API CDMO division. Offers ICH stability studies, technology transfer, analytical laboratory services, and EU batch testing/release.

T.Man Pharma Company Limited

Thailand

T.Man Pharma Company Limited is a Thai public company established in 1991, specializing in the production and distribution of modern drugs, herbal medicines, food supplements, cosmetics, and health products. With 500-999 employees, the company operates GMP PIC/s certified manufacturing facilities and serves both domestic and international markets. Listed as a CMO/CDMO on CPHI and registered with FDA Thailand.

Ultratech India Limited

India

Ultratech India Limited is an integrated Indian pharmaceutical company established in 1992, manufacturing pharmaceutical finished dosage forms, Active Pharmaceutical Ingredients, and drug intermediates. They specialize in pulmonary drug delivery systems (DPI and pMDI inhalation products) and offer Custom Research and Manufacturing Services (CRAMS) including custom synthesis, process development, private labeling, and contract manufacturing. Extensive API portfolio covers cardiovascular, antifungal, antihistamine, anti-asthmatics, antiviral, erectile dysfunction, and other therapeutic segments. WHO GMP, ISO 9001, ISO 14001 certified.

UNI-PHARMA S.A.

Greece

UNI-PHARMA S.A. is a major Greek pharmaceutical company (part of the Tsetis Group) with over 60 years of operations. It researches, develops, produces, and distributes pharmaceutical products, food supplements, and medical devices. It holds the first place in sales (units) among purely Greek companies in the Greek pharmaceutical market. The company offers contract manufacturing services (listed as CMO/CDMO on PharmaSource) while also marketing its own extensive portfolio of generic medicines across multiple therapeutic categories. Their product range includes a very wide array of small-molecule generics.

Wacker Biotech

Germany

Wacker Biotech is the CDMO division of Wacker Chemie AG, specializing in advanced biologics manufacturing including proteins, plasmid DNA, mRNA, LNP formulations, live microbial products, and vaccines. With over 30 years of experience and five GMP-compliant facilities in Germany, the Netherlands, and the United States, Wacker Biotech offers process development through commercial-scale manufacturing with E. coli-based technology platforms.

WuXi Biologics

China

WuXi Biologics is a leading global Contract Research, Development, and Manufacturing Organization (CRDMO) for biologics, with over 12,000 employees across the US, Ireland, Germany, China, and Singapore. The company provides end-to-end solutions from discovery through commercial manufacturing for biologics including monoclonal antibodies, bispecifics, ADCs, vaccines, and mRNA products using both mammalian and microbial expression systems.

Xellia Pharmaceuticals

China

Xellia Pharmaceuticals is the global leader in fermentation-based non-beta-lactam anti-infective APIs and finished dosage forms (FDFs). With over 120 years of pharmaceutical manufacturing heritage, they supply APIs and sterile injectables to over 500 pharmaceutical companies across 80 countries. Also operates as a CMO for third-party sterile injectable production.

Xi'an Wanlong Pharmaceutical

China

Xi'an Wanlong Pharmaceutical Co., Ltd. is a comprehensive modern pharmaceutical enterprise founded in 1995, primarily producing formulations, APIs, and intermediates with GMP and DMF compliance. The Yangling facility spans 200,000 sq.m. with 18 production lines for injections, tablets, capsules, powder, and raw materials.

XL LABORATORIES PVT LTD

India

XL Laboratories Pvt Ltd is an EU GMP, PIC/s, TGA, and WHO GMP approved pharmaceutical formulations and nutraceuticals research and manufacturing company established in 2001. It holds Star Export House status from the Indian Ministry of Commerce for outstanding international market performance, with presence in 40+ countries.

Zhejiang Ausun Pharmaceutical Co Ltd

China

Zhejiang Ausun Pharmaceutical Co., Ltd., established in 2010 and listed on the Shanghai Stock Exchange (2017), is a Chinese pharmaceutical company based in the Taizhou Bay Economic Development Zone, Zhejiang Province. The company specializes in R&D, production, and sale of formulations (capsules, tablets) and active pharmaceutical ingredients. They are FDA-registered (FEI 3009065969) with 3 FDA inspections (1 NAI, 2 VAI, 0 OAI), have 2 FDA-approved products (capsule and tablet, oral route), hold US DMF filings, and have participated in 1 clinical trial (Infectious Disease). They employ 1,000-4,999 people. Their website was blocked (403 WAF), so details come primarily from search results and FDA regulatory data.

Zydus Lifesciences Ltd

India

Zydus Lifesciences Ltd. (formerly Cadila Healthcare) is a major Indian pharmaceutical company headquartered in Ahmedabad, Gujarat, ranked 4th in the Indian pharma industry with 29,000+ employees globally. In June 2025, Zydus entered the global biologics CDMO business by acquiring Agenus Inc.'s U.S. manufacturing facilities in Emeryville and Berkeley, California for $75M upfront (plus $50M milestones), now operating as independent subsidiary Zylidac Bio LLC. These facilities provide end-to-end biologics development and manufacturing from pre-clinical to commercial stages, including monoclonal antibody manufacturing for Phase-3 immuno-oncology products (Botensilimab and Balstilimab). Zydus has 15 FDA-registered facilities, 156 FDA-approved products across capsules, tablets, creams, gels, injectables (including liposomal), ointments, suppositories, and transdermal patches. They have 58 FDA inspections (25 NAI, 28 VAI, 5 OAI) and 51 recalls (2 Class I, 40 Class II, 9 Class III). Manufacturing sites span Gujarat, Maharashtra, Goa, Himachal Pradesh, Sikkim (India), plus US (Vermont, Pennsylvania, Missouri) and Brazil. Their CDMO services are specifically the biologics arm through Zylidac Bio -- the broader Zydus business is primarily own-brand generic pharmaceuticals.

ACON Pharmaceuticals

United States

ACON Pharmaceuticals Inc is a specialty contract research organization (CRO) based in Cranbury, New Jersey, focused on drug product development. They specialize in drug delivery systems including siRNA, mRNA, liposomes, nanocrystals, and complex generics development via the 505(b)(2) pathway. They are primarily a development-focused CRO, not a manufacturing organization.

Aldevron

United States

Aldevron is a US-based CDMO specializing in manufacturing plasmid DNA, mRNA, and related products for gene therapy, cell therapy, gene editing, and RNA vaccines/therapeutics. The company offers custom and catalog products from research grade through cGMP, with capabilities including mRNA production with LNP encapsulation and fill/finish, supporting discovery through commercialization.

Anemocyte S.r.l.

Italy

Anemocyte is an Italian biotech manufacturing organization (self-described as a BMO) specializing in plasmid DNA, mRNA, and viral vector development and manufacturing for the cell and gene therapy sector. They provide GMP-grade contract manufacturing services for advanced therapies.

Antheia Bio

United States

Antheia is a U.S.-based next-generation pharmaceutical ingredient manufacturer using advanced biosynthesis (yeast fermentation) to produce Key Starting Materials (KSMs) and APIs. They partner with companies like TAPI and Phlow Corp to commercialize biosynthetic pharmaceutical ingredients, focusing on addressing drug shortages through domestic biomanufacturing.

Aspen API

Netherlands

Aspen API (part of Aspen Global) is a CDMO specializing in complex chemical API and peptide manufacturing. With multiple FDA- and EMA-inspected manufacturing sites, they offer end-to-end API development from process R&D to commercial-scale production, including high-potency API (HPAPI) manufacturing with containment capabilities. They are part of the larger Aspen CDMO network.

Batavia Biosciences

Netherlands

Batavia Biosciences is a Netherlands-based CDMO dedicated to viral vector and vaccine development. They provide process development, GMP manufacturing through their Batavia Biomanufacturing division, and offer proprietary technologies including HIP-Vax, SCOUT, SATIRN, STEP, and SIDUS platforms. They support clients from bench to bedside in viral vectors, viral vaccines, recombinant proteins, and oncolytic viruses.

Biologics Manufacturing Centre (BMC) Inc.

Canada

Biologics Manufacturing Centre (BMC) Inc. is a Canadian end-to-end GMP biomanufacturing facility with a public good mandate, established to secure domestic biologics supply. Licensed by Health Canada (DEL 3-002766-A and 3-002818-A) to manufacture and test biological products and vaccines. The facility is BSL-2 accredited and supports orphan drug development for rare and genetic diseases. Subsidiary of the National Research Council Canada.

C2 PHARMA

India

C2 PHARMA is a European pharmaceutical group established in 2014 that manufactures and distributes active pharmaceutical ingredients (APIs) and complex chemical compounds from natural and synthetic origins. The company specializes in ophthalmic and niche APIs with headquarters in Cork, Ireland.

celares GmbH

Germany

celares GmbH is a German CDMO focused on the development and manufacturing of polymer-based drug delivery excipients and bioconjugate drugs. The company specializes in PEGylation technology and conjugate vaccine development, with collaborations including EMD Millipore and NOF Corporation. celares has been acquired by Biosynth, which expanded its capabilities into conjugate vaccines and bioconjugation services.

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB)

Taiwan

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB), founded in 1964 and operating as Cenra API Solutions, is one of the largest API manufacturers in Taiwan. The company provides cGMP toll manufacturing and contract research services with FDA/EU-approved facilities, producing APIs across antifungal, immunosuppressant, oncology, cardiovascular, and peptide drug categories.

CKD BiO

South Korea

CKD BiO is a South Korean contract development and manufacturing organization specializing in APIs and intermediates at its cGMP facility approved by US and EU authorities. The company has over 1,500 m3 of fermentation capacity ranging from 12 m3 to 100 m3 scale, with expertise across a broad spectrum of microorganisms including streptomyces, fungi, bacteria, and yeast, supported by decades of accumulated know-how in fermentation-based API manufacturing.

Emil Pharmaceutical Industries Pvt Ltd

India

Emil Pharmaceutical Industries Pvt. Ltd. is an Indian CDMO founded in 1989, headquartered in Mumbai with three manufacturing units in MIDC Tarapur, Maharashtra. The company manufactures pharmaceuticals, nutraceuticals, and OTC formulations including tablets, capsules, powders, liquids, creams, and ointments. Emil has partnered as a CDMO with global companies including Abbott, Mylan, Pfizer, GSK, USV, and MSD, and exports to over 25 countries with certifications from WHO, ISO 9001, NAFDAC Nigeria, and FDA Ghana.

Fraunhofer Institute for Cell Therapy and Immunology (IZI)

Germany

The Fraunhofer Institute for Cell Therapy and Immunology (IZI) in Leipzig is a contract research and GMP manufacturing institute specializing in cell and gene therapy, vaccines, and biologics. The institute provides GMP-compliant manufacturing of clinical trial materials (ATMPs and biologicals), process development for pharmaceutical manufacturing, and regulatory support for manufacturing authorizations and approvals.

LABIANA

Spain

LABIANA is a Spanish pharmaceutical group founded in 1958 with over 60 years of history, now listed on BME Growth. They operate as a CDMO serving both human and veterinary pharmaceutical sectors. LABIANA has three EU-GMP manufacturing plants: Labiana Pharmaceuticals in Corbera de Llobregat (Barcelona) for human pharma with sterile liquids, non-sterile liquids, and non-sterile solids; and Labiana Life Sciences in Terrassa (Barcelona) plus Veterinarski Zavod Subotica in Serbia for veterinary products including biologicals (viral, bacterial, and autogenous vaccines). The company is a benchmark in contract manufacturing for sterile forms and also manufactures/distributes Fosfomycin Trometamol under its own brand. Their subsidiary Zoleant Pharmaceuticals handles global marketing of niche alternative brand medicines.

LGC Biosearch Technologies

United Kingdom

LGC Biosearch Technologies is a CDMO and part of the global LGC life sciences group, specializing in custom oligonucleotide synthesis and nucleic acid therapeutics manufacturing. The company manufactures siRNA, antisense oligos, and other nucleic acid-based therapeutic APIs under GMP conditions, alongside genomics reagents and instruments for research use.

List Biological Laboratories Inc

United States

List Biological Laboratories Inc (List Labs) is a US-based CDMO with over 45 years of experience specializing in microbial-derived biologics and live biotherapeutic products (LBPs). The company provides cGMP manufacturing services for bacterial fermentation, harvest, purification, lyophilization, and encapsulation of therapeutic and vaccine products including polysaccharides, toxins, toxoids, and recombinant proteins. List Labs also manufactures nearly 100 research reagents.

Matrix Pharma Corp. Private Ltd. (CDMO BU)

India

Matrix Pharma Corp. Private Ltd. (CDMO BU) is a leading Indian integrated API manufacturer and CDMO specializing in active pharmaceutical ingredients with particular expertise in complex molecules, high-potency drugs, and APIs across therapeutic areas including antiretrovirals, antivirals, antihypertensives, cardiovascular, and CNS therapies. The company operates six state-of-the-art manufacturing facilities with over 3,850 kL installed capacity, including dedicated units for ARVs, peptides, and iron complexes. FDA-registered with 5 FEI numbers and extensive inspection history (25 inspections: 9 NAI, 15 VAI, 1 OAI). Recently inaugurated an oncology manufacturing facility in Vizag.

Melody Healthcare

India

Melody Healthcare Pvt Ltd is an Indian pharmaceutical company and part of The Singhania Group, specializing in the manufacturing of active pharmaceutical ingredients (APIs). The company focuses on niche, complex chemistry-driven APIs with expertise in respiratory and antibiotic therapeutic areas. Melody Healthcare has DMFs designed for global registrations and supplies APIs to over 105 countries. Key differentiators include micronization capability (particle size engineering from early-stage through commercial scale), backward integration from basic building blocks, and quality-by-design approach adhering to ICH guidelines. The company holds certifications from US-FDA, EDQM (ANSM France), TGA Australia, MFDS Korea, WHO-GMP, CDSCO, and ISO 9001/14001.

Metrochem API Pvt Ltd

India

Metrochem API Pvt Ltd is a vertically integrated Indian pharmaceutical API manufacturer based in Hyderabad, approved by USFDA (EIR), WHO-GMP, COEFPRIS, KFDA, and ISO 9001. The company has over 300 API and pellet registrations across various countries. Their manufacturing facility spans 50,000 sqm with 700kl reaction volume. Metrochem has received China NMPA approval for Teneligliptin hydrobromide and manufactures APIs such as Rabeprazole Sodium and Efinaconazole.

Minaris Advanced Therapies

United States

Minaris Advanced Therapies (formerly Hitachi Chemical Advanced Therapeutics Solutions) is a global cell and gene therapy CDMO with 25+ years of autologous expertise. The company provides end-to-end GMP manufacturing and advanced testing services for gene-edited autologous (CAR-T, TCR-T), allogeneic (NK, HSC, iPSC), non-edited cell therapies, and vaccines. FDA-registered manufacturing site with FEI number.

Nortec Química S.A.

Brazil

Nortec Quimica is the largest Active Pharmaceutical Ingredient (API) manufacturer in Latin America, operating since 1985 in Duque de Caxias, Brazil. The company produces over 50 APIs, with strong expertise in local anesthetics (lidocaine, bupivacaine, prilocaine, articaine, mepivacaine), as well as escetamine and olanzapine. Nortec offers a complete CDMO platform from R&D through commercial-scale API production.

Numaferm GmbH

Germany

Numaferm GmbH is a German biotech company specializing in the biochemical production of peptides and proteins using its proprietary Numaswitch and Numatech expression platforms. The company offers contract development and manufacturing services from discovery through commercial/GMP supply, partnering with established CMOs for large-scale production. Numaferm has completed over 200 successful peptide projects and is ISO 9001:2015 certified.

Pen-G (Penicillin General Integrated Industrial Co.)

Oman

Pen-G (Penicillin General Integrated Industrial Co.) is an Oman-based biotechnology manufacturing company and the first of its kind in the MENA region. The company operates a state-of-the-art fermentation plant for the production of Penicillin G and 6-APA (6-Aminopenicillanic acid), the key precursor for semi-synthetic penicillin antibiotics. It also produces semi-synthetic penicillin APIs and Penicillin V.

ProteoGenix SAS

France

ProteoGenix SAS is a French antibody production company founded in 2003, providing integrated solutions for custom antibody development, recombinant protein expression, and bioproduction services. The company offers therapeutic antibody discovery, humanization using proprietary AI, ADC development, bispecific antibody development, CAR-T platforms, and custom cell line development across 6 manufacturing sites. ProteoGenix serves the therapeutics, diagnostics, research, and animal health markets.

Protheragen-ING

China

Protheragen-ING is a China-based comprehensive integrated service provider specializing in drug development and biotechnology solutions. The company offers both small molecule and large molecule (antibody, ADC, protein therapy) development and manufacturing services, with an extensive pipeline of available drug development projects spanning antibody therapies, oncolytic virotherapy, cell therapy (CAR-T), and small molecules. Protheragen is FDA-registered for API manufacture and operates project incubation and equity investment services for drug candidates.

Recipharm AB

Sweden

Rechon Life Science AB is a subsidiary/entity within the Recipharm group, the global CDMO headquartered in Stockholm, Sweden. This entry represents the same Recipharm organization (same website: recipharm.com) with its extensive global manufacturing footprint of 15+ FDA-registered FEI numbers and 52 FDA inspections. The Perplexity research confirms Recipharm's specialization in oral solid dose, inhalation, sterile manufacturing, and HPAPI capabilities. Rechon may represent a specific Recipharm site or legacy entity. Duplicate of Recipharm AB entry -- capabilities are identical.

ReiThera Srl

Italy

ReiThera is an Italian CDMO dedicated to process development and GMP manufacturing of viral vectors for genetic vaccines and advanced therapy medicinal products (ATMPs). They have extensive expertise in developing scalable processes for Adeno-Associated Vectors (AAV), Lentivirus, Adenoviral vectors (AdV), Modified Vaccinia Ankara, and Herpes Simplex Vectors. Their state-of-the-art facility in Rome features stirred-tank bioreactors at 50L, 200L, 1000L, and 2000L scales, fixed-bed bioreactors, a filling suite, and quality control laboratories. They also develop their own vaccine candidates (e.g., GRAd-COV2).

REMEDICA LTD

Cyprus

REMEDICA is a Cyprus-based pharmaceutical manufacturer that has been operating for over four decades, distributing products in more than 160 countries. They manufacture generics across multiple therapeutic areas and dosage forms (solid oral dose, liquids, semi-solids, sterile injectables) and offer contract manufacturing (CMO/CDMO) services. They have long-standing relationships with NGOs (UNICEF, WHO, UNRWA). They focus on B2B partnerships, own-brand commercialization (Cyprus, Eastern EU, Asia, Middle East, Africa, LATAM), and NGO supply.

RiboPro B.V.

Netherlands

RiboPro B.V. is a Netherlands-based mRNA CDMO providing GMP-grade mRNA manufacturing, LNP (lipid nanoparticle) formulation services, and contract research. The company has over a decade of mRNA-specific experience and offers proprietary technologies including RiboStealth sequence optimization and RiboFlux GMP manufacturing platform. RiboPro serves customers ranging from early discovery through commercial production of mRNA therapeutics and vaccines.

Sanzyme Biologics Pvt Ltd

India

Sanzyme Biologics is one of India's leading probiotic manufacturers with over five decades of fermentation expertise, originally established by Daiichi Sankyo, Japan. The company operates two manufacturing facilities in Hyderabad with combined fermentation capacity exceeding 350,000L, providing contract manufacturing services for probiotic strains, enzymes, and metabolites for pharmaceutical, food, and supplement applications.

Saurav Chemicals Ltd

India

Saurav Chemicals Ltd (SCL Lifesciences) is an Indian manufacturer of Active Pharmaceutical Ingredients and advanced intermediates, with over three decades of experience serving regulated markets in Europe, the USA, and Japan. The company is the largest supplier of cephalosporin and penem intermediates and also provides CDMO services, custom synthesis, and mRNA vaccine ingredients.

Scientific Protein Laboratories (SPL)

United States

Scientific Protein Laboratories (SPL) is a CDMO specializing in cGMP biopharmaceutical manufacturing of APIs from biological sources, with over 30 years of experience. Core products include heparin derivatives (Heparin Sodium USP) and pancreatic enzymes (Pancreatin USP, Pancrelipase USP). The company also provides custom development services including fermentation, natural product extractions, and recovery/purification of therapeutic proteins from preclinical through commercial scale.

Scinai Immunotherapeutics

Israel

Scinai Immunotherapeutics is a NASDAQ-listed biopharmaceutical company that provides boutique biologics CDMO services through its Scinai Bioservices business unit, alongside its own I&I therapeutics pipeline. The CDMO offers end-to-end drug development and manufacturing from molecule selection through Phase 3 manufacturing, with over 20 years of experience in recombinant protein development. Scinai acquired a manufacturing site in Yavne, Israel from Recipharm and established a US subsidiary (Scinai Bioservices Inc.).

SEQENS

Canada

SEQENS is a global integrated CDMO and specialty ingredients leader with 15 production sites across 9 countries and 5 R&D centers. The company manufactures custom and generic APIs, intermediates, excipients, custom lipids for drug delivery (mRNA/siRNA, LNP), HPAPIs, and specialty chemicals. SEQENS also operates CELLforCURE, an EMA-authorized CDMO for Advanced Therapy Medicinal Products (ATMPs/Cell & Gene Therapy). The company serves 1,500+ customers in 80+ countries with approximately 2,700 employees and ~1B EUR revenue.